Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Year-over-year book value per share growth
Latest
73.83%
↑ 1185% vs avg
Percentile
P94
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
5.75%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 73.83% |
| Q3 2025 | -7.55% |
| Q2 2025 | -6.27% |
| Q1 2025 | -18.81% |
| Q4 2024 | 9.26% |
| Q3 2024 | -6.33% |
| Q2 2024 | 27.73% |
| Q1 2024 | -9.35% |
| Q4 2023 | -8.01% |
| Q3 2023 | -7.29% |
| Q2 2023 | -10.15% |
| Q1 2023 | 29.85% |
| Q4 2022 | -20.27% |
| Q3 2022 | 21.87% |
| Q2 2022 | -15.53% |
| Q1 2022 | -10.72% |
| Q4 2021 | -17.25% |
| Q3 2021 | 85.41% |
| Q2 2021 | -16.20% |
| Q1 2021 | 17.30% |
| Q4 2020 | -10.25% |
| Q3 2020 | -24.78% |
| Q2 2020 | 64.69% |
| Q1 2020 | -19.35% |
| Q4 2019 | -32.87% |
| Q3 2019 | 150.73% |
| Q2 2019 | -18.33% |
| Q1 2019 | -37.50% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |